600267.SH
海正药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.06
−7.80%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
24.3x
EV/EBITDA
7.4x
Market Cap
CNY 14.23B
MomentumView details →
1D Return
−7.80%
YTD Return
+17.69%
RSI (14)
40.1
ValuationView details →
P/E (Fwd)
24.3x
EV/EBITDA
7.4x
Market Cap
CNY 14.23B
RSI (14)
40.1
MomentumView details →
1D Return
−7.80%
YTD Return
+17.69%
Similar companies
Latest newsMore news →
Hisun Pharmaceutical signed a strategic cooperation agreement with Chengdu Xingji Space Exploration Technology Co., Ltd. (Xingji Development) to enter the space biopharmaceutical sector.8d agoHisun Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 636 million yuan, up 112.82% year-on-year, with revenue of 4.475 billion yuan, down 14.76%.11d ago